Capricor Therapeutics, Inc. (CAPR)
NASDAQ·Healthcare·Biotechnology
$8.59
-8.08%
Mkt Cap $492.29M
Analyst Ratings
Buy
4
Hold
4
Sell
0
Price Target (20 analysts)
$5.83
Range $3.50 – $7.00
Implied Upside
-32.1%
Consensus $5.83 vs current $8.59
NASDAQ·Healthcare·Biotechnology
$8.59
-8.08%
Mkt Cap $492.29M
Buy
4
Hold
4
Sell
0
Price Target (20 analysts)
$5.83
Range $3.50 – $7.00
-32.1%
Consensus $5.83 vs current $8.59